India’s Covaxin effectively neutralises Delta variant of Covid, says U.S.' health research institute
The National Institute of Health said results of two studies of blood serum from people who had received Covaxin suggest that the vaccine generates antibodies that effectively neutralise the B.1.1.7 and B.1.617 variants of SARS-CoV-2.
Admin
0
3
The National Institute of Health said results of two studies of blood serum from people who had received Covaxin suggest that the vaccine generates antibodies that effectively neutralise the B.1.1.7 and B.1.617 variants of SARS-CoV-2.
